Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.18 USD | -0.96% | -7.00% | -38.55% |
05-16 | Replimune Group, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
04-08 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.55% | 318M | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+37.09% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+27.49% | 12.08B | |
+22.40% | 11.94B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- Replimune Group's Fiscal Q4 Net Loss Widens